Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance

NCT ID: NCT01972100

Last Updated: 2013-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study hypothesis is a improved muscle fatigue resistance induced by low-level laser therapy applied between sets of intense exercises.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Low-level laser therapy Muscle fatigue resistance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low-level laser therapy (LLLT)

Use of low-level laser therapy (LLLT) to induce a muscle fatigue resistance in intense exercises

Group Type ACTIVE_COMPARATOR

Low-level laser therapy (808nm)

Intervention Type DEVICE

Use of low-level laser therapy(LLLT)or placebo-LLLT applied on quadriceps femoris muscles between sets of isokinetic knee flexion-extension exercise

isokinetic exercise

Intervention Type OTHER

Placebo low-level laser therapy (Placebo)

Use of low-level laser therapy (LLLT) placebo to induce a muscle fatigue resistance

Group Type ACTIVE_COMPARATOR

isokinetic exercise

Intervention Type OTHER

Placebo low-level laser therapy

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low-level laser therapy (808nm)

Use of low-level laser therapy(LLLT)or placebo-LLLT applied on quadriceps femoris muscles between sets of isokinetic knee flexion-extension exercise

Intervention Type DEVICE

isokinetic exercise

Intervention Type OTHER

Placebo low-level laser therapy

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Low-level laser therapy; Placebo low-level laser theraphy Laser device (808nm; 100mW; DMC®, Brazil). Isokinetic knee flexion-extension exercise

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy males
* physically active
* aged between 18-28 years old

Exclusion Criteria

* smoker
* under medicine
* lower limb lesions limiting the flexion-extension of the knee joint
Minimum Eligible Age

18 Years

Maximum Eligible Age

28 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Federal do Rio Grande do Norte

OTHER

Sponsor Role collaborator

Cleber Ferraresi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cleber Ferraresi

Cleber Ferraresi

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cleber Ferraresi, MD

Role: PRINCIPAL_INVESTIGATOR

Universidade Federal de Sao Carlos

Wouber Hérickson de Brito Vieira, PhD

Role: STUDY_DIRECTOR

Universidade Federal do Rio Grande do Norte

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Federal Univesity of Rio Grande do Norte

Rio Grande Do Norte, Natal, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Felismino AS, Costa EC, Aoki MS, Ferraresi C, de Araujo Moura Lemos TM, de Brito Vieira WH. Effect of low-level laser therapy (808 nm) on markers of muscle damage: a randomized double-blind placebo-controlled trial. Lasers Med Sci. 2014 May;29(3):933-8. doi: 10.1007/s10103-013-1430-2. Epub 2013 Sep 5.

Reference Type BACKGROUND
PMID: 24005882 (View on PubMed)

Ferraresi C, Hamblin MR, Parizotto NA. Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light. Photonics Lasers Med. 2012 Nov 1;1(4):267-286. doi: 10.1515/plm-2012-0032.

Reference Type BACKGROUND
PMID: 23626925 (View on PubMed)

Vieira WH, Ferraresi C, Perez SE, Baldissera V, Parizotto NA. Effects of low-level laser therapy (808 nm) on isokinetic muscle performance of young women submitted to endurance training: a randomized controlled clinical trial. Lasers Med Sci. 2012 Mar;27(2):497-504. doi: 10.1007/s10103-011-0984-0. Epub 2011 Aug 26.

Reference Type BACKGROUND
PMID: 21870127 (View on PubMed)

Ferraresi C, de Brito Oliveira T, de Oliveira Zafalon L, de Menezes Reiff RB, Baldissera V, de Andrade Perez SE, Matheucci Junior E, Parizotto NA. Effects of low level laser therapy (808 nm) on physical strength training in humans. Lasers Med Sci. 2011 May;26(3):349-58. doi: 10.1007/s10103-010-0855-0. Epub 2010 Nov 18.

Reference Type BACKGROUND
PMID: 21086010 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEP/UFRN 401/09

Identifier Type: -

Identifier Source: org_study_id